Published in Pediatr Infect Dis J on January 01, 1995
Timing of development of measles-specific immunoglobulin M and G after primary measles vaccination. Clin Diagn Lab Immunol (1999) 1.14
A study of maternally derived measles antibody in infants born to naturally infected and vaccinated women. Epidemiol Infect (1996) 0.94
Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of age. J Infect Dis (2013) 0.80
Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial. J Infect Dis (2016) 0.79
Measles antibody: reevaluation of protective titers. J Infect Dis (1990) 3.77
Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J Pediatr (1977) 2.66
Measles vaccination and inflammatory bowel disease. Lancet (1995) 2.63
Transfer function analysis of the circulation: unique insights into cardiovascular regulation. Am J Physiol (1991) 2.42
Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther (2005) 2.36
Recovery from a viral respiratory infection. II. Passive transfer of immune spleen cells to mice with influenza pneumonia. J Immunol (1981) 2.19
Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice. J Immunol (1981) 2.04
The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate. J Virol (2000) 2.04
Role of virus strain in conventional and enhanced measles plaque neutralization test. J Virol Methods (1981) 1.96
T wave alternans during exercise and atrial pacing in humans. J Cardiovasc Electrophysiol (1997) 1.92
Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J Virol (1999) 1.91
Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood (1998) 1.89
Measles infection of human mononuclear cells. I. Acute infection of peripheral blood lymphocytes and monocytes. J Exp Med (1975) 1.86
Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines. N Engl J Med (1990) 1.82
Modulation of cardiac autonomic activity during and immediately after exercise. Am J Physiol (1989) 1.81
Effect of breast-feeding on antibody response to conjugate vaccine. Lancet (1990) 1.72
Power law behavior of RR-interval variability in healthy middle-aged persons, patients with recent acute myocardial infarction, and patients with heart transplants. Circulation (1996) 1.67
Biomarker evidence for a major preservation pathway of sedimentary organic carbon. Science (2006) 1.66
Hypohidrotic ectodermal dysplasia with hypothyroidism. J Pediatr (1981) 1.61
Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system. Pediatr Infect Dis J (2001) 1.60
Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent "cold" staphylococcal abscesses. Lancet (1974) 1.56
A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms. N Engl J Med (1986) 1.53
Transfer of measles, mumps, and rubella antibodies from mother to infant. Its effect on measles, mumps, and rubella immunization. Am J Dis Child (1979) 1.51
Inhibition of lymphocyte stimulation by measles virus. J Immunol (1975) 1.47
Pathogenesis of neurotropic arbovirus infections. Curr Top Microbiol Immunol (1968) 1.46
Familial enteropathy with villous edema and immunoglobulin G2 subclass deficiency. J Pediatr (1994) 1.44
Fatal measles infection in marmosets pathogenesis and prophylaxis. Infect Immun (1980) 1.43
Comparison of esophageal, rectal, axillary, bladder, tympanic, and pulmonary artery temperatures in children. J Pediatr (1998) 1.38
Late postpoliomyelitis muscular atrophy: clinical, virologic, and immunologic studies. Rev Infect Dis (1984) 1.38
Ontogeny of the immune response as a basis of childhood disease. J Pediatr (1980) 1.37
Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease. Vaccine (1989) 1.35
Defective NK cell activation in X-linked lymphoproliferative disease. J Immunol (2000) 1.31
Energy balance during recovery from malnutrition. Am J Clin Nutr (1976) 1.31
Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines. Am J Epidemiol (1988) 1.26
Predicting sudden cardiac death from T wave alternans of the surface electrocardiogram: promise and pitfalls. J Cardiovasc Electrophysiol (1996) 1.26
Sensitive neutralization test for virus antibody. 1. Mumps antibody. Arch Virol (1978) 1.25
Evidence that cytotoxic T cells are part of the host's response to influenza pneumonia. J Exp Med (1978) 1.25
Standardization of poliovirus neutralizing antibody tests. Rev Infect Dis (1984) 1.23
Inactivated poliovirus vaccine: past and present experience. Vaccine (1996) 1.22
Host defense mechanisms against influenza virus: interaction of influenza virus with murine macrophages in vitro. Infect Immun (1978) 1.19
Neurotropic properties of measles virus in hamsters and mice. J Infect Dis (1971) 1.16
Smoking and caffeine and alcohol intake during pregnancy in a northern population: effect on fetal growth. CMAJ (1992) 1.15
Augmentation of human influenza A virus-specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS). Virology (1999) 1.15
Diphtheria and tetanus immunity among blood donors in Toronto. CMAJ (1997) 1.14
The use of outbreak information in the interpretation of clustering of reported cases of Escherichia coli O157 in space and time in Alberta, Canada, 2000-2002. Epidemiol Infect (2006) 1.13
Analysis of long term heart rate variability: methods, 1/f scaling and implications. Comput Cardiol (1988) 1.13
Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays. Pediatrics (1983) 1.13
Efficient estimation of the heart period power spectrum suitable for physiologic or pharmacologic studies. Am J Cardiol (1990) 1.11
L-tetramisole. Enhancement of human lymphocyte response to antigen. Clin Exp Immunol (1975) 1.11
Enzyme-linked immunosorbent assay (ELISA) for measles antibody. A comparison with haemagglutination inhibition, immunofluorescence and plaque neutralization tests. Rev Inst Med Trop Sao Paulo (1993) 1.11
Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants. J Pediatr (1997) 1.10
Immune responses during measles infection in immunosuppressed Rhesus monkeys. J Immunol (1977) 1.10
Subacute sclerosing panencephalitis: experimental infection in primates. Science (1977) 1.10
Polar lipids of archaebacteria in sediments and petroleums. Science (1982) 1.09
Low-frequency oscillations in arterial pressure and heart rate: a simple computer model. Am J Physiol (1989) 1.09
Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein. Virology (1998) 1.08
Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age. Pediatr Infect Dis J (1994) 1.07
The plaque-neutralization test as a measure of prior exposure to measles virus. J Infect Dis (1987) 1.07
Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team. Pediatrics (1996) 1.06
Phenotypic expressions of CCR5-delta32/delta32 homozygosity. J Acquir Immune Defic Syndr (1999) 1.05
An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine (2000) 1.05
Analysis of complement-dependent antibody-mediated lysis of target cells acutely infected with measles. J Immunol (1976) 1.04
Adverse reactions to the preschool (fifth) dose of adsorbed diphtheria-pertussis-tetanus vaccine in Canadian children. CMAJ (1991) 1.04
Transfer factor in rat coccidiosis. Cell Immunol (1972) 1.03
Significant decline in pneumonia admission rate after the introduction of routine 2+1 dose schedule heptavalent pneumococcal conjugate vaccine (PCV7) in children under 5 years of age in Kielce, Poland. Eur J Clin Microbiol Infect Dis (2010) 1.03
Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity. Pediatrics (1995) 1.03
Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines. J Virol (1999) 1.03
Persistence of measles antibody after revaccination. J Infect Dis (1992) 1.03
Hemagglutinin-specific complement-dependent cytolytic antibody response to influenza infection. J Exp Med (1978) 1.02
Reduced measles immunity in infants in a well-vaccinated population. Pediatr Infect Dis J (1992) 1.01
Beta 1 integrin (CD29) expression on human postnatal T cell subsets defined by selective CD45 isoform expression. J Immunol (1991) 1.00
Impact of revaccinating children who initially received measles vaccine before 10 months of age. Pediatrics (1986) 1.00
Cerebellar hypoplasia and frontal lobe cognitive deficits in disorders of early childhood. Neuropsychologia (1997) 1.00
Paraffin embedding techniques for immunofluorescent demonstration of neurotropic viruses. Acta Virol (1966) 1.00
Investigation of a measles outbreak in a fully vaccinated school population including serum studies before and after revaccination. Pediatr Infect Dis J (1993) 0.98
Electrical alternans during rest and exercise as predictors of vulnerability to ventricular arrhythmias. Am J Cardiol (1997) 0.98
Effect of breast-feeding on immune response to BCG vaccination. Lancet (1989) 0.98
Comparison of indirect immunofluorescence test for measles antibodies with haemagglutination inhibition and plaque neutralization tests. Rev Inst Med Trop Sao Paulo (1992) 0.97
Detection of group B arboviruses in chick embryo cell cultures by the fluorescent antibody method. Acta Virol (1965) 0.96
Deleterious effect of thimerosal on the potency of inactivated poliovirus vaccine. Vaccine (1994) 0.96
Sensitive plaque neutralization assay for parainfluenza virus types 1, 2, and 3 and respiratory syncytial virus. J Clin Microbiol (1981) 0.96
Genetic variability of group A and B human respiratory syncytial viruses isolated from 3 provinces in China. Arch Virol (2007) 0.96
Experimental measles encephalitis in normal and cyclophosphamide-treated rhesus monkeys. J Infect Dis (1972) 0.96
The regulation of type 7 adenylyl cyclase by its C1b region and Escherichia coli peptidylprolyl isomerase, SlyD. J Biol Chem (2000) 0.95
Immunogenicity of wild and attenuated varicella-zoster virus strains in rhesus monkeys. J Med Virol (1984) 0.94
Markers for measles virus. II. Tissue culture properties. Arch Gesamte Virusforsch (1972) 0.94
The mumps virus neurovirulence safety test in Rhesus monkeys: a comparison of mumps virus strains. J Infect Dis (1999) 0.93
Comparison of time- and frequency domain-based measures of cardiac parasympathetic activity in Holter recordings after myocardial infarction. Am J Cardiol (1989) 0.93
The plasma membrane channel ORAI1 mediates detrimental calcium influx caused by endogenous oxidative stress. Cell Death Dis (2013) 0.93
Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence of alcohol. Curr Med Res Opin (2008) 0.93
Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine (2012) 0.93
Human respiratory syncytial virus surface glycoproteins F, G and SH form an oligomeric complex. Arch Virol (2001) 0.92
Markers for measles virus. I. Physical properties. Arch Gesamte Virusforsch (1972) 0.91
Occult T wave alternans in long QT syndrome. J Cardiovasc Electrophysiol (1996) 0.91
Susceptibility of tamarins (Saguinus) to measles virus. Lab Anim Sci (1980) 0.91